Disrupting VE-cadherin Y685 phosphorylation inhibits development of experimental diabetic and prediabetic retinopathy
Yixin Wang1, Hongpeng Huang1, Feng Shao1
1Experimental Pharmacology Mannheim, European Center for Angioscience (ECAS).
Abstract:
Diabetic retinopathy involves early retinal vascular barrier breakdown and pericyte loss, yet the initiating molecular events remain poorly defined. Vascular endothelial cadherin (VE-cadherin), a key regulator of endothelial integrity, is notably reduced in diabetic and prediabetic nucleoside diphosphate kinase B-deficient (NDPKB-deficient) mouse retinas, particularly in the retinal deep capillary layer, and this decline precedes pericyte loss. In vitro, high glucose (HG) and NDPKB deficiency induced VE-cadherin Y685 phosphorylation, promoting its junctional internalization, activating the hexosamine biosynthesis pathway, and increasing angiopoietin 2 (Ang2), resulting in impaired endothelial barrier function and disrupting pericyte attachment. Preventing Y685 phosphorylation through VE-cadherin Y685F mutation blocked these HG- and NDPKB-driven pathological effects. Pharmacological intervention experiments identified protein O-linked β-N-acetyl glucosamine (O-GlcNAc) modification as a mediator of Y685-dependent Ang2 upregulation. In vivo, VE-cadherin Y685F-knockin mice were protected from diabetes- and prediabetes-induced vascular hyperpermeability, exhibited reduced protein O-GlcNAcylation and Ang2 induction, and maintained neuronal function. O-GlcNAc-enriched retinal proteomics further showed that the Y685F mutation restored balanced neurovascular and mitochondrial pathways. These findings highlight the potential of targeting VE-cadherin Y685 phosphorylation as a promising therapeutic approach to maintain retinal vascular integrity and attenuate the pathological progression of diabetic and prediabetic retinopathy.
Insights
Diabetic retinopathy involves early retinal vascular barrier breakdown. Targeting vascular endothelial cadherin (VE-cadherin) Y685 phosphorylation may protect against this condition and maintain neuronal function.
Area of Science:
- Ophthalmology
- Vascular Biology
- Diabetic Complications
Background:
- Diabetic retinopathy (DR) is characterized by early retinal vascular barrier breakdown and pericyte loss, with initiating molecular events poorly understood.
- Vascular endothelial cadherin (VE-cadherin), crucial for endothelial integrity, is reduced in diabetic/prediabetic mouse retinas, preceding pericyte loss.
- Nucleoside diphosphate kinase B (NDPKB) deficiency is implicated in DR pathogenesis.
Purpose of the Study:
- To investigate the role of VE-cadherin phosphorylation in diabetic retinopathy.
- To identify molecular mechanisms linking high glucose and NDPKB deficiency to endothelial dysfunction.
- To explore therapeutic strategies targeting VE-cadherin in diabetic retinopathy.
Main Methods:
- In vitro studies using high glucose (HG) and NDPKB-deficient endothelial cells.
- VE-cadherin Y685F mutation to prevent phosphorylation.
- In vivo studies using VE-cadherin Y685F-knockin mice under diabetic/prediabetic conditions.
- Retinal proteomics analysis.
Main Results:
- HG and NDPKB deficiency induced VE-cadherin Y685 phosphorylation, internalization, and increased angiopoietin 2 (Ang2) via the hexosamine biosynthesis pathway.
- VE-cadherin Y685F mutation blocked these effects, preventing endothelial barrier dysfunction and pericyte loss.
- In vivo, Y685F-knockin mice showed protection against diabetes-induced vascular hyperpermeability, reduced O-GlcNAcylation and Ang2, and preserved neuronal function.
- Proteomics revealed restoration of neurovascular and mitochondrial pathways in Y685F mice.
Conclusions:
- VE-cadherin Y685 phosphorylation is a key mediator of high glucose- and NDPKB deficiency-induced retinal vascular damage.
- Targeting VE-cadherin Y685 phosphorylation presents a promising therapeutic strategy for diabetic and prediabetic retinopathy.
- Maintaining retinal vascular integrity through this approach can preserve neuronal function.
More Related Videos
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
Published on: December 26, 2017
04:36An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Related Concept Videos
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Inhibition of Cdk Activity
